On a recent trip to the Bay Area, many people we met shared the same concern: how can we effectively spend the wave of new philanthropic funding which is about to hit? Which organizations can absorb t...

In the first blog in this series, Rachel Glennerster and I suggested that new philanthropists could spend tens of billions of dollars on proven cost-effective interventions. This blog is about buying ...

In the first blog in this series, Rachel Glennerster and I suggested that new philanthropists could spend tens of billions of dollars on proven cost-effective interventions. This blog is about buying ...

More than one billion people are affected by poverty-related and neglected diseases. Yet funding for research and development remains far below need. One solution is to create the missing incentive. A...

Neonatal sepsis is a leading cause of mortality in low- and middle-income countries (LMICs). The current diagnostic standard, blood culture, has long turnaround times and high infrastructure requireme...

Vaccines are among the most impactful global health innovations. They drive major declines in child mortality and prevent an estimated 3.5 to 5 million deaths every year. The golden age of vaccine dev...

Vaccines are among the most impactful global health innovations. They drive major declines in child mortality and prevent an estimated 3.5 to 5 million deaths every year. The golden age of vaccine dev...